PIRS - Pieris Pharmaceuticals misses by $0.02 beats on revenue May, 10 2019 07:06 AM Pieris Pharmaceuticals Inc. Pieris Pharmaceuticals (NASDAQ:PIRS): Q1 GAAP EPS of -$0.20 misses by $0.02.More news on: Pieris Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...